PMC:7309518 / 470-607 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":70,"end":78},"obj":"Body_part"},{"id":"T2","span":{"begin":84,"end":89},"obj":"Body_part"},{"id":"T3","span":{"begin":90,"end":101},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma65132"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma82780"}],"text":"g symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. Emerging cases of COVID-19–trigger"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":84,"end":89},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"g symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. Emerging cases of COVID-19–trigger"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":121,"end":129},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"g symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. Emerging cases of COVID-19–trigger"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":84,"end":89},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"g symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. Emerging cases of COVID-19–trigger"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":70,"end":78},"obj":"Chemical"},{"id":"T2","span":{"begin":90,"end":101},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_33563"}],"text":"g symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. Emerging cases of COVID-19–trigger"}

{"project":"LitCovid-PubTator","denotations":[{"id":"16","span":{"begin":58,"end":63},"obj":"Disease"},{"id":"17","span":{"begin":121,"end":129},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"MESH:C000657245"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"g symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. Emerging cases of COVID-19–trigger"}